Brigade Enterprises Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 30, 2025, 10:11 am

Quick Insight

Brigade Enterprises Ltd, with a share price of 966 and a market cap of 23,592 Cr., is trading at a P/E of 34.8, indicating a premium valuation. The company's ROE stands at 14.8%, while ROCE is at 13.3%, reflecting decent profitability. With an OPM of 28%, Brigade has shown efficiency in operations. The firm's high P/BV ratio of 6.16x suggests the stock is valued significantly above its book value. Furthermore, its ICR of 2.77x indicates the company has a healthy interest coverage ratio. However, investors may need to monitor the high level of borrowings at ₹5,464 Cr. Overall, while Brigade Enterprises shows promising profitability and operational efficiency, its valuation metrics and borrowing levels warrant careful consideration.

Competitors of Brigade Enterprises Ltd

All Competitor Stocks of Brigade Enterprises Ltd

Quarterly Result

Last Updated: August 20, 2025, 12:35 pm

Below is a detailed analysis of the quarterly data for Brigade Enterprises Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 1,281.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,460.00 Cr. (Mar 2025) to 1,281.00 Cr., marking a decrease of 179.00 Cr..
• For Expenses, as of Jun 2025, the value is 958.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,044.00 Cr. (Mar 2025) to 958.00 Cr., marking a decrease of 86.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 323.00 Cr.. The value appears to be declining and may need further review. It has decreased from 416.00 Cr. (Mar 2025) to 323.00 Cr., marking a decrease of 93.00 Cr..
• For OPM %, as of Jun 2025, the value is 25.00%. The value appears to be declining and may need further review. It has decreased from 28.00% (Mar 2025) to 25.00%, marking a decrease of 3.00%.
• For Other Income, as of Jun 2025, the value is 52.00 Cr.. The value appears to be declining and may need further review. It has decreased from 72.00 Cr. (Mar 2025) to 52.00 Cr., marking a decrease of 20.00 Cr..
• For Interest, as of Jun 2025, the value is 106.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 107.00 Cr. (Mar 2025) to 106.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 76.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 76.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 194.00 Cr.. The value appears to be declining and may need further review. It has decreased from 306.00 Cr. (Mar 2025) to 194.00 Cr., marking a decrease of 112.00 Cr..
• For Tax %, as of Jun 2025, the value is 18.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 18.00%.
• For Net Profit, as of Jun 2025, the value is 158.00 Cr.. The value appears to be declining and may need further review. It has decreased from 249.00 Cr. (Mar 2025) to 158.00 Cr., marking a decrease of 91.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 6.13. The value appears to be declining and may need further review. It has decreased from 10.10 (Mar 2025) to 6.13, marking a decrease of 3.97.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 22, 2025, 5:31 pm

Balance Sheet

Last Updated: August 11, 2025, 1:46 pm

Below is a detailed analysis of the balance sheet data for Brigade Enterprises Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 244.00 Cr.. The value appears strong and on an upward trend. It has increased from 231.00 Cr. (Mar 2024) to 244.00 Cr., marking an increase of 13.00 Cr..
• For Reserves, as of Mar 2025, the value is 5,394.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,285.00 Cr. (Mar 2024) to 5,394.00 Cr., marking an increase of 2,109.00 Cr..
• For Borrowings, as of Mar 2025, the value is 5,464.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 5,470.00 Cr. (Mar 2024) to 5,464.00 Cr., marking a decrease of 6.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 10,973.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8,874.00 Cr. (Mar 2024) to 10,973.00 Cr., marking an increase of 2,099.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 22,076.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 17,860.00 Cr. (Mar 2024) to 22,076.00 Cr., marking an increase of 4,216.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 6,899.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,747.00 Cr. (Mar 2024) to 6,899.00 Cr., marking an increase of 1,152.00 Cr..
• For CWIP, as of Mar 2025, the value is 138.00 Cr.. The value appears strong and on an upward trend. It has increased from 78.00 Cr. (Mar 2024) to 138.00 Cr., marking an increase of 60.00 Cr..
• For Investments, as of Mar 2025, the value is 43.00 Cr.. The value appears to be declining and may need further review. It has decreased from 50.00 Cr. (Mar 2024) to 43.00 Cr., marking a decrease of 7.00 Cr..
• For Other Assets, as of Mar 2025, the value is 14,995.00 Cr.. The value appears strong and on an upward trend. It has increased from 11,985.00 Cr. (Mar 2024) to 14,995.00 Cr., marking an increase of 3,010.00 Cr..
• For Total Assets, as of Mar 2025, the value is 22,076.00 Cr.. The value appears strong and on an upward trend. It has increased from 17,860.00 Cr. (Mar 2024) to 22,076.00 Cr., marking an increase of 4,216.00 Cr..

However, the Borrowings (5,464.00 Cr.) are higher than the Reserves (5,394.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Brigade Enterprises Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 19.56. This value is within the healthy range. It has increased from 12.64 (Mar 23) to 19.56, marking an increase of 6.92.
• For Diluted EPS (Rs.), as of Mar 24, the value is 19.51. This value is within the healthy range. It has increased from 12.64 (Mar 23) to 19.51, marking an increase of 6.87.
• For Cash EPS (Rs.), as of Mar 24, the value is 30.43. This value is within the healthy range. It has increased from 23.09 (Mar 23) to 30.43, marking an increase of 7.34.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 147.83. It has increased from 133.10 (Mar 23) to 147.83, marking an increase of 14.73.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 148.19. It has increased from 133.46 (Mar 23) to 148.19, marking an increase of 14.73.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 211.89. It has increased from 149.29 (Mar 23) to 211.89, marking an increase of 62.60.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 58.93. This value is within the healthy range. It has increased from 42.37 (Mar 23) to 58.93, marking an increase of 16.56.
• For PBIT / Share (Rs.), as of Mar 24, the value is 45.85. This value is within the healthy range. It has increased from 28.74 (Mar 23) to 45.85, marking an increase of 17.11.
• For PBT / Share (Rs.), as of Mar 24, the value is 24.61. This value is within the healthy range. It has increased from 11.87 (Mar 23) to 24.61, marking an increase of 12.74.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 17.35. This value is within the healthy range. It has increased from 9.45 (Mar 23) to 17.35, marking an increase of 7.90.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 19.54. This value is within the healthy range. It has increased from 12.63 (Mar 23) to 19.54, marking an increase of 6.91.
• For PBDIT Margin (%), as of Mar 24, the value is 27.81. This value is within the healthy range. It has decreased from 28.38 (Mar 23) to 27.81, marking a decrease of 0.57.
• For PBIT Margin (%), as of Mar 24, the value is 21.64. This value exceeds the healthy maximum of 20. It has increased from 19.24 (Mar 23) to 21.64, marking an increase of 2.40.
• For PBT Margin (%), as of Mar 24, the value is 11.61. This value is within the healthy range. It has increased from 7.95 (Mar 23) to 11.61, marking an increase of 3.66.
• For Net Profit Margin (%), as of Mar 24, the value is 8.19. This value is within the healthy range. It has increased from 6.33 (Mar 23) to 8.19, marking an increase of 1.86.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 9.22. This value is within the healthy range. It has increased from 8.45 (Mar 23) to 9.22, marking an increase of 0.77.
• For Return on Networth / Equity (%), as of Mar 24, the value is 12.87. This value is below the healthy minimum of 15. It has increased from 9.18 (Mar 23) to 12.87, marking an increase of 3.69.
• For Return on Capital Employeed (%), as of Mar 24, the value is 11.97. This value is within the healthy range. It has increased from 8.69 (Mar 23) to 11.97, marking an increase of 3.28.
• For Return On Assets (%), as of Mar 24, the value is 2.52. This value is below the healthy minimum of 5. It has increased from 1.77 (Mar 23) to 2.52, marking an increase of 0.75.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 1.39. This value exceeds the healthy maximum of 1. It has increased from 1.32 (Mar 23) to 1.39, marking an increase of 0.07.
• For Total Debt / Equity (X), as of Mar 24, the value is 1.52. This value exceeds the healthy maximum of 1. It has increased from 1.43 (Mar 23) to 1.52, marking an increase of 0.09.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.28. It has increased from 0.18 (Mar 23) to 0.28, marking an increase of 0.10.
• For Current Ratio (X), as of Mar 24, the value is 1.16. This value is below the healthy minimum of 1.5. It has increased from 1.11 (Mar 23) to 1.16, marking an increase of 0.05.
• For Quick Ratio (X), as of Mar 24, the value is 0.30. This value is below the healthy minimum of 1. It has increased from 0.27 (Mar 23) to 0.30, marking an increase of 0.03.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 0.02. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 23) to 0.02, marking an increase of 0.02.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 10.22. This value is below the healthy minimum of 20. It has decreased from 11.85 (Mar 23) to 10.22, marking a decrease of 1.63.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 6.12. This value is below the healthy minimum of 20. It has increased from 5.70 (Mar 23) to 6.12, marking an increase of 0.42.
• For Earning Retention Ratio (%), as of Mar 24, the value is 89.78. This value exceeds the healthy maximum of 70. It has increased from 88.15 (Mar 23) to 89.78, marking an increase of 1.63.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 93.88. This value exceeds the healthy maximum of 70. It has decreased from 94.30 (Mar 23) to 93.88, marking a decrease of 0.42.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 2.77. This value is below the healthy minimum of 3. It has increased from 2.25 (Mar 23) to 2.77, marking an increase of 0.52.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 1.82. This value is below the healthy minimum of 3. It has increased from 1.40 (Mar 23) to 1.82, marking an increase of 0.42.
• For Enterprise Value (Cr.), as of Mar 24, the value is 25,130.78. It has increased from 13,910.61 (Mar 23) to 25,130.78, marking an increase of 11,220.17.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 5.13. This value exceeds the healthy maximum of 3. It has increased from 4.04 (Mar 23) to 5.13, marking an increase of 1.09.
• For EV / EBITDA (X), as of Mar 24, the value is 18.45. This value exceeds the healthy maximum of 15. It has increased from 14.23 (Mar 23) to 18.45, marking an increase of 4.22.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 4.42. This value exceeds the healthy maximum of 3. It has increased from 3.18 (Mar 23) to 4.42, marking an increase of 1.24.
• For Retention Ratios (%), as of Mar 24, the value is 89.77. This value exceeds the healthy maximum of 70. It has increased from 88.14 (Mar 23) to 89.77, marking an increase of 1.63.
• For Price / BV (X), as of Mar 24, the value is 6.16. This value exceeds the healthy maximum of 3. It has increased from 3.45 (Mar 23) to 6.16, marking an increase of 2.71.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 4.42. This value exceeds the healthy maximum of 3. It has increased from 3.18 (Mar 23) to 4.42, marking an increase of 1.24.
• For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness